Melatonin Receptor 1B Polymorphisms in Women with Systemic Lupus Erythematosus

Melatonin Receptor 1B Polymorphisms in Women with Systemic Lupus Erythematosus

ARTIGO ORIGINAL Melatonin receptor 1b polymorphisms in women with systemic lupus erythematosus Tanev D 1, Robeva R 2, Andonova S 3, Decheva V 3, Tomova A 2, Kumanov P 2, Savov A 3, Rashkov R 1, Kolarov Z 1 ACTA REUMATOL PORT. 2016;41:62-67 AbstrAct immunostimulatory and antiapoptotic role 1. A bidirec - tional association between the pineal gland and the im - Aim: The pineal hormone melatonin could exert an im - mune system has been suggested based on the im - portant influence on the immune system and autoi mmu - munomodulating features of melatonin and the pineal nity. Its effect on the immunocompetent cells might be regulation by different lymphokines 2. Moreover, dif - mediated at least partially through specific melatonin re - ferent immune cells and tissues are able to synthesize ceptors. However, the role of melatonin - me latonin re - melatonin 3. The hormone might act directly on im - ceptor 1B (MTNR1B) interrelations in human autoim - munocompetent cells and it could influence the mune diseases is still unknown. Therefore, the present develop ment of autoimmune diseases as well as their study aimed to investigate the possible influence of the clinical expression 1. Circadian rhythm disturbances of MTNR1B gene polymorphisms for the development and the melatonin secretion were already described in pa - clinical expression of systemic lupus erythematosus (SLE). tients with rheumatoid arthritis 4. Methods: 109 female SLE patients and 101 healthy The effects of melatonin on immunocompetent cells women were genotyped for the MTNR1B rs1562444, and hematopoiesis are accomplished at least in part rs10830962 and rs10830963 polymorphisms. through its action on the specific melatonin receptors Results: No genotype distribution differences were (reviewed in Pandi-Perumal et al. 2008) 5. Experimental found between patients and controls. The presence of studies indicated that melatonin receptor type 1B MTNR1B rs10830963 C/C genotype was related to in - (MTNR1B) could be involved in melatonin-induced en - creased prevalence of leucopenia compared to genotypes hancement of cell-mediated and humoral immune res - C/G and G/G after Bonferroni correction for multiple ponse 6. However, it is not clarified, if the single nu - comparisons [36.5% vs. 14.5%, p=0.014]. Moreo ver, cleotide polymorphisms of the MTNR1B gene might in - the rs10830963 G/G carriers had lower number of lupus fluence the interactions between the melatonin and criteria in comparison to patients with C/C genotype. melatonin receptor as well as their complex effects Conclusions: The present data suggested that MTNR1B on the immune system and autoimmunity. A significant polymorphisms could influence the clinical features in lu - as sociation was found between the MTNR1B rs1562444 pus patients, and especially the susceptibility to leucopenia. polymorphism and the development of rheumatoid fac - tor positive rheumatoid arthritis in Korean patients 7, Keywords : Genetic association; Melatonin receptor 1B; while the role of MNTR1B polymorphisms in systemic Polymorphisms; Systemic lupus erythematosus; Leu - lupus erythematosus (SLE) was not clarified. copenia, Myelosupression. Therefore, our study aimed to investigate the possi - ble role of MTNR1B gene polymorphisms rs1562444, rs10830962 and rs10830963 for the clinical expres - IntroductIon sion of SLE. The pineal hormone melatonin is widely known for its MAterIAls And Methods 1. Clinic of Rheumatology, Medical University, Sofia 2. Clinical Center of Endocrinology and Gerontology, Medical subjects University, Sofia 3. National Genetic Laboratory, USHATOG “Maichin dom”, Medical Two hundred and ten Caucasian women were inclu - University, Sofia ded in the study. One hundred and nine patients (mean ÓRGÃO OfICIAL dA SOCIEdAdE PORTUGUESA dE REUMATOLOGIA 62 Melatonin receptor 1b polyMorphisMs in woMen with systeMic lupus erytheMatosus age 41.72±11.71 years [20-67]) were recruited from gation step was 7 minutes at 72°C. PCR products for the Department of Rheumatology. They fulfilled the rs10830962, rs10830963 and rs1562444 were di - modified 1997 American College Rheumatology gested with restriction endonucleases - HinfI, PvuII (ACR) classification criteria for systemic lupus erythe - and NlaIII (New England BioLabs Inc, USA), respecti - matosus 8. The Systemic Lupus International Collabo - vely. The digested products were analyzed on 2.5% rating Clinics/ACR (SLICC) index 9 were determined agarose gel stained with ethidium bromide. Since the by one rheumatologist (D.T.). All women underwent G to C (rs10830962), C to G (rs10830963) and A to a complete general assessment and the presence of the G (rs1562444) transitions create an endonuclease lupus features such as malar rash, discoid rash, pho - recognition site, the PCR fragment following enzyme tosensitivity, oral ulcer, non-erosive arthritis, serositis, digestion reveals two types of alleles. The absence of renal disorder, neurological disorder, hematological res triction site for rs10830962 G/C referred to allele G disorder (including presence of anemia, leucopenia, (210 bp) and the presence of restriction site - referred lymphopenia or thrombocytopenia), immunological to allele C (with 184 bp and 26 bp fragments). For disorder (including positive anti-DNA antibodies, rs10830963 C/G polymorphism the sizes of detected posi tive anti-Smith antibodies or positive finding of alleles were 105 bp and 20 bp (allele G) and 125 bp antiphospholipid antibodies) as well as the presence of (allele C). The amplification region of 400 bp for antinuclear antibodies were registered. The previous rs1562444 A/G was digested with NlaIII restriction and current medication with corticosteroids and im - endonuclease and two fragments were revealed – 319 munosuppressors such as cyclophosphamide, aza - bp and 81 bp. The A to G transition creates additio nal thioprine, and methotrexate was registered. NlaIII restriction site. The 2.5% agarose gel electro - One hundred and one age matched controls (mean phoresis reveals three different patterns of genotypes: age 39.36±11.97 years [22-68]) were collected from G/G (with 319 bp and 81 bp bands), G/A (with 319 bp, the medical staff and students. They were all clinically 163 bp, 156 bp and 81 bp) and A/A (163 bp, 156 bp healthy women without connective tissue diseases. The and 81 bp). Several randomly selected samples were experimental protocol was explained to all participants sequenced and their sequence identities were confir - and written informed consent was obtained. The study med. The distribution of all investigated genotypes in was approved by the institutional ethic commission. healthy females was in agreement with the Hardy- -Weinberg equilibrium. The genetic team was not MelAtonIn receptor 1b polyMorphIsMs aware of any clinical data concerning SLE patients. All participating women provided peripheral blood samples for DNA. Genotyping was performed by PCR- stAtIstIcAl AnAlysIs RFLP analysis. The three different regions rs1562444, The results were presented as mean ±SD (median) for rs10830962 and rs10830963 were amplified by PCR continuous variables or as a frequency (%) for in three reactions. Each PCR was performed in a total dichotomou s variables. Categorical data were analyzed vo lume of 15 µl containing 2.0 mmol/L MgCl2, 0.5U through χ2 test or Fisher’s exact test. After a Kol - Pri me Taq DNA polymerase with the appropriate mogorov–Smirnov test for normality of the distribution buffer (GenetBio, Korea) and 0.2 pmol/µl of each of differences between two groups were established with the primers: an independent t-test or Mann-Whitney test. Compari - rs10830962: F 5’–TACTAGATATTAGCTGTGTGCTAGT - sons between three groups were calculated through one- GACT–3’/ R 5’ TCTGGGCAACTCAGTGAAACC–3’; way ANOVA with post hoc Bonferroni test (equal rs10830963 : F 5’–ATGCTAAGAATTCACACCAGCT-3’/ R varian ces assumed) and Tamhane’s T2 test (unequal 5’–CACAGTGCAGACTGTTTTCTAATC–3’; variances assumed) or non-parametric Kruskal-Wallis rs1562444 : F 5’–GAAAACACTCTTGGTGGTGTCTT–3’/ R test according to normality of the distribution. All re - 5’-GATGTGGTGGCTATGTGTGTGTGTA-3’. sults were considered significant at the 0.05 level. Lo - Thermal cycling was performed with initial denatu - gistic regression analysis was used where appropriate. ration 95°C for 7 min, followed by 33 cycles of 95°C The Bonferroni adjustment for multiple testing was ap - for 30 sec/ 60°C for 30 sec/ 72°C for 60 sec (for plied and the significance of the p value was set at 0.017 rs10830962); 95°C for 30 sec/ 54°C for 30 sec/ 72°C (0.05/3 considering the three investigated polymor - for 30 sec (for rs10830963); 95°C for 30 sec/ 60°C for phisms). Statistical analysis was conducted through 60 sec/ 72°C for 30 sec (for rs1562444). The final elon - SPSS v. 11 for Windows (SPSS, Chicago, IL, USA). ÓRGÃO OfICIAL dA SOCIEdAdE PORTUGUESA dE REUMATOLOGIA 63 tanev D et al results MTNR1B rs1562444 Healthy women SLE patients 0% AA AA 20% 40% AG AG 60% 80% GG GG 100% A total of 100 healthy women and 106 female patients were genotyped for the single nucleotide polymor - phism rs1562444 in the melatonin receptor type 1B gene. No significant differences in the genotype fre - quencies of patients and controls were observed ( Figu - re 1 ). Considering clinical characteristics of the SLE pa - tients, the rs1562444 polymorphism was found to be related to the development of leucopenia, while no other relations with ACR criteria were established (Table I). Patients with G/G genotype had increased risk for leucopenia

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    6 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us